Skip to main content

BioCommunique Article

Bringing you the latest financial and strategic news from top leaders in life science over the past two weeks.

Iovance and AmpliPhi Close Public Offerings, Ionis Splits $3M Breakthrough Prize, REVOLUTION Medicines Acquires Warp Drive Bio

  • 2018-10-18T02:23:00.000+0000
  • California
  • Author: Lauren Panetta

10/17/18 – GenomeWeb
Illumina Accelerator Program Adds Five Startups to Eighth Investment Cycle

10/17/18 – Achaogen
Achaogen Submits Marketing Authorization Application to the European Medicines Agency for Plazomicin

10/17/18 – Iovance Biotherapeutics
Iovance Biotherapeutics, Inc. Announces Closing of $252 Million Common Stock Public Offering

10/17/18 – aTyr Pharma
aTyr Pharma Presents at American Society of Human Genetics 2018 Meeting

10/17/18 – The San Diego Union-Tribune
Frank Bennett of Ionis Shares $3 Million Breakthrough Prize

10/17/18 – Thermo Fisher Scientific
Thermo Fisher Scientific CE Marks Oncomine Dx Target Test

10/17/18 – Avidity Biosciences
Avidity Biosciences Receives Investment from CureDuchenne

10/17/18 – FierceBiotech
Novartis tasks Foundation with companion diagnostic development for cancer treatments

10/16/18 – AmpliPhi
AmpliPhi Biosciences Announces Closing of Public Offering

10/16/18 – Bionano Genomics
Bionano Genomics’ Structural Variation Results Presented at ASHG 2018 Provide Insights in Cancer and Genetic Disease

10/16/18 – Revolution Medicines
REVOLUTION Medicines Acquires Warp Drive Bio to Expand Drug Discovery Portfolio Focused on Frontier Oncology Targets

10/16/18 – Abide Therapeutics
Abide Therapeutics Announces Initiation of Phase 2 Clinical Trial of ABX-1431 in Tourette Syndrome

10/13/18 – The San Diego Union-Tribune
Salk Institute's Janelle Ayres gets $3.5 million NIH grant

10/12/18 – The San Diego Union-Tribune
For cancer, Fate Therapeutics tests another kind of immune cell

10/11/18 – FierceBiotech
Bristol-Myers, Compugen ally to test checkpoint combinations

10/10/18 – Xconomy
CRISPR Therapeutics, Vertex Get FDA Green Light for Sickle Cell Test

10/10/18 – The San Diego Union-Tribune
HIV vaccine candidate from Scripps Research starts human testing

10/10/18 – FierceBiotech
Ionis may have finally found a home for dry AMD drug with Roche

10/10/18 – FierceBiotech
Myriad, Pfizer sign BRCA IVD commercial deal before FDA verdict

10/10/18 – FierceBiotech
Neurocrine, Jnana team up to discover CNS drugs

10/8/18 – Celgene
Celgene Announces Phase 3 STYLE Study of OTEZLA® (apremilast) in Moderate to Severe Scalp Psoriasis Met Primary Endpoint

10/8/18 – FierceBiotech
GSK helps immunometabolism startup Sitryx to $30M round

10/4/18 – The San Diego Union-Tribune
Flavor biotech Senomyx receives $74 million takeover bid following financial turmoil